SHAREHOLDER NOTICE:  Brodsky & Smith, LLC Announces an Investigation of Express Scripts Holding Company – ESRX

BALA CYNWYD, July 18, 2018 /Access Wire/ – Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors Express Scripts Holding Company (“Express Scripts” or “the Company”) (Nasdaq – ESRX-News) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Cigna Corporation. (“Cigna”).

Under the terms of the transaction, Express Scripts shareholders will receive only $48.75 in cash and 0.2434 of a share of the newly combined company  for each share of Express Scripts stock they own. The investigation concerns whether the Board of Express Scripts breached their fiduciary duties to shareholders and whether Cigna is underpaying for the Company. The transaction may undervalue the Company and may not be in the Express Scripts shareholders best interests. For example, an analyst has set a $101.00 per share price target for the stock.

If you own shares of Express Scripts stock and wish to discuss the legal ramifications of  the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA  19004, or calling toll free 877-LEGAL-90.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.